ATE457177T1 - Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe - Google Patents
Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffeInfo
- Publication number
- ATE457177T1 ATE457177T1 AT01935002T AT01935002T ATE457177T1 AT E457177 T1 ATE457177 T1 AT E457177T1 AT 01935002 T AT01935002 T AT 01935002T AT 01935002 T AT01935002 T AT 01935002T AT E457177 T1 ATE457177 T1 AT E457177T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- respiratory diseases
- compositions
- treatment
- combination therapy
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 238000002648 combination therapy Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 229940100601 interleukin-6 Drugs 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20140400P | 2000-05-03 | 2000-05-03 | |
| PCT/US2001/014193 WO2001082966A1 (en) | 2000-05-03 | 2001-05-03 | Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE457177T1 true ATE457177T1 (de) | 2010-02-15 |
Family
ID=22745679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01935002T ATE457177T1 (de) | 2000-05-03 | 2001-05-03 | Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7208162B2 (de) |
| EP (1) | EP1278546B1 (de) |
| JP (1) | JP2003531867A (de) |
| AT (1) | ATE457177T1 (de) |
| AU (2) | AU6113701A (de) |
| CA (1) | CA2407292A1 (de) |
| DE (1) | DE60141274D1 (de) |
| ES (1) | ES2338098T3 (de) |
| WO (1) | WO2001082966A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60142614D1 (de) * | 2000-01-27 | 2010-09-02 | Medimmune Inc | Inität |
| EP1259547B1 (de) * | 2000-03-01 | 2012-07-11 | Medimmune, Inc. | Hochwirksame rekombinante antikörper und methode zu deren herstellung |
| DE60141274D1 (de) | 2000-05-03 | 2010-03-25 | Medimmune Inc | Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe |
| US6855493B2 (en) * | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| GB2388194A (en) * | 2002-05-02 | 2003-11-05 | Nec Technologies | Remote medical monitor utilising a mobile telephone |
| US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
| US7425618B2 (en) * | 2002-06-14 | 2008-09-16 | Medimmune, Inc. | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| JP2005533861A (ja) * | 2002-07-25 | 2005-11-10 | メデュームン，インコーポレーテッド | 抗ＲＳＶ、抗ｈＭＰＶ、および抗ＰＩＶ抗体を使用するＲＳＶ、ｈＭＰＶ、およびＰＩＶの治療法と予防法 |
| AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
| US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
| WO2006041970A2 (en) * | 2004-10-08 | 2006-04-20 | Abbott Biotechnology Ltd. | Treatment of respiratory syncytial virus (rsv) infection |
| AU2005302453A1 (en) * | 2004-10-29 | 2006-05-11 | Medimmune, Llc | Methods of preventing and treating RSV infections and related conditions |
| BRPI0715115A2 (pt) * | 2006-08-03 | 2013-06-04 | Vaccinex Inc | anticorpo monoclonal isolado, molÉcula de Ácido nucleico isolada, vetor de expressço, cÉlula hospedeira, mÉtodos para tratar uma doenÇa, e para produzir um anticorpo monoclonal isolado, uso do anticorpo monoclonal isolado, e, composiÇço farmacÊutica |
| EP1997830A1 (de) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| IL303833A (en) | 2016-10-21 | 2023-08-01 | Adimab Llc | Respiratory syncytial virus antibodies and methods for their production and use |
| JP7265984B2 (ja) | 2016-10-21 | 2023-04-27 | アディマブ， エルエルシー | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| WO2018075974A2 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2181673T3 (es) * | 1991-05-01 | 2003-03-01 | Jackson H M Found Military Med | Procedimiento de tratamiento de las enfermedades respiratorias infecciosas. |
| US5824307A (en) * | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| EP1098644A1 (de) * | 1998-07-20 | 2001-05-16 | Bristol-Myers Squibb Company | Antivirale substituierte benzimidazole |
| DE60141274D1 (de) | 2000-05-03 | 2010-03-25 | Medimmune Inc | Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe |
-
2001
- 2001-05-03 DE DE60141274T patent/DE60141274D1/de not_active Expired - Lifetime
- 2001-05-03 US US09/848,377 patent/US7208162B2/en not_active Expired - Lifetime
- 2001-05-03 CA CA002407292A patent/CA2407292A1/en not_active Abandoned
- 2001-05-03 ES ES01935002T patent/ES2338098T3/es not_active Expired - Lifetime
- 2001-05-03 AT AT01935002T patent/ATE457177T1/de not_active IP Right Cessation
- 2001-05-03 AU AU6113701A patent/AU6113701A/xx active Pending
- 2001-05-03 EP EP01935002A patent/EP1278546B1/de not_active Expired - Lifetime
- 2001-05-03 JP JP2001579839A patent/JP2003531867A/ja active Pending
- 2001-05-03 AU AU2001261137A patent/AU2001261137B2/en not_active Expired
- 2001-05-03 WO PCT/US2001/014193 patent/WO2001082966A1/en active Application Filing
-
2007
- 2007-03-06 US US11/714,670 patent/US20070224204A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001261137C1 (en) | 2001-11-12 |
| CA2407292A1 (en) | 2001-11-08 |
| ES2338098T3 (es) | 2010-05-04 |
| JP2003531867A (ja) | 2003-10-28 |
| EP1278546B1 (de) | 2010-02-10 |
| AU6113701A (en) | 2001-11-12 |
| EP1278546A1 (de) | 2003-01-29 |
| WO2001082966A1 (en) | 2001-11-08 |
| DE60141274D1 (de) | 2010-03-25 |
| US20020051787A1 (en) | 2002-05-02 |
| US20070224204A1 (en) | 2007-09-27 |
| US7208162B2 (en) | 2007-04-24 |
| AU2001261137B2 (en) | 2006-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE457177T1 (de) | Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200300293A1 (ru) | Противовоспалительные конденсированные пирролокарбазолы | |
| UY35542A (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
| EA200900663A1 (ru) | Лечение синдрома "сухого глаза" | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| ID27787A (id) | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan | |
| EA200400735A1 (ru) | 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
| DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| EA200401081A1 (ru) | Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro | |
| BRPI0418887A (pt) | nucleosìdeos de 3-beta-d-ribofuranossiltiazol[4,5-d] pirimidina e usos dos mesmos | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
| EA200200518A1 (ru) | Способ и композиция для лечения заболеваний легких | |
| HUP0203050A2 (hu) | Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények | |
| DE602005027228D1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind | |
| ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
| DE60120111D1 (de) | Verwendung einer emap-ii-rezeptor-antagonisten verbindung zur behandlung pulmonaler hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |